Does Ascorbic Acid Reduce Sympathoexcitation in CHF? | NCT00550121 | Trialant
CompletedInterventionalNot ApplicableUpdated Oct 15, 2008
Does Ascorbic Acid Reduce Sympathoexcitation in CHF?
ClinicalTrials.gov ID
NCT00550121
Lead Sponsor
Radboud University Medical CenterOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Last Update Posted
Oct 15, 2008Estimated
Start Date
Aug 2007
Completion Date
Apr 2008Actual
Brief Summary
In CHF central sympathetic activity is increased. ROS formation seems to play a role in this process. This study analyzes the effect of vitamin C as an antioxidant on central sympathetic activity in CHF
Heart Failure
vitamin C
placebo
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No data available
Eligibility Criteria
Inclusion Criteria:
Heart failure of at least New York Heart Association (NYHA) class II
Left ventricular ejection fraction (LVEF) <= 40%
Age 20-80 years
Exclusion Criteria:
Necessity of short-term PCI, CABG or heart transplantation,
Chronic disease of the autonomic nervous system,
diabetes mellitus,
use of tricyclic antidepressant drugs and/or a-adrenergic receptor antagonists.
Allocation
Randomized
Interventional Model
Crossover Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
Radboud University Nijmegen Medical Centre
Nijmegen, 6500 HB, Netherlands
Lead Sponsor
Radboud University Medical CenterOTHER
Collaborators
ZonMw: The Netherlands Organisation for Health Research and DevelopmentOTHER